Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

1 records in Main database

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	EHT102 by EuHearing	Shanghai EuHearing Therapeutics Co., Ltd	Therapeutic	-	Gene Therapy	Phase 1/2	Active	Details checkedClinical trial listing only	trial · Priority 2	90%	PediatricGenetic+3	Hearing LossSensorineural Hearing Loss+3

Shanghai EuHearing Therapeutics Co., Ltd · Gene Therapy · Phase 1/2

ActiveTherapeutic

Evidence

trial

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss

Population

PediatricGeneticCongenitalOTOF / DFNB9